Immunobiology and immunopharmacology of organ allograft rejection

Manikkam Suthanthiran, Terry B. Strom

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Much has been learned regarding immunobiological mechanisms responsible for the rejection of histoincompatible allografts. There has also been considerable progress in our understanding of mechanisms responsible for tolerance. The new knowledge gained regarding graft destructive alloimmunity process and the mechanisms of action of immunosuppressants have resulted in solid organ graft survival rates that are in excess of 80% at one year posttransplantation. The principles of tolerance mechanisms are yet to be successfully applied in the clinic. In this review, molecular and cellular mechanisms of action of clinically useful immunosuppressive drugs are reviewed from the perspective of regulation of the anti-allograft repertory.

Original languageEnglish
Pages (from-to)161-171
Number of pages11
JournalJournal of Clinical Immunology
Volume15
Issue number4
DOIs
Publication statusPublished - 1 Jul 1995
Externally publishedYes

Fingerprint

Immunosuppressive Agents
Allografts
Transplants
Tissue Survival
Graft Survival
Pharmaceutical Preparations

Keywords

  • immunobiology
  • immunosuppressive drugs
  • rejection
  • tolerance
  • Transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Immunobiology and immunopharmacology of organ allograft rejection. / Suthanthiran, Manikkam; Strom, Terry B.

In: Journal of Clinical Immunology, Vol. 15, No. 4, 01.07.1995, p. 161-171.

Research output: Contribution to journalArticle

@article{0bc11740913f49bea41b24dc34d1786d,
title = "Immunobiology and immunopharmacology of organ allograft rejection",
abstract = "Much has been learned regarding immunobiological mechanisms responsible for the rejection of histoincompatible allografts. There has also been considerable progress in our understanding of mechanisms responsible for tolerance. The new knowledge gained regarding graft destructive alloimmunity process and the mechanisms of action of immunosuppressants have resulted in solid organ graft survival rates that are in excess of 80{\%} at one year posttransplantation. The principles of tolerance mechanisms are yet to be successfully applied in the clinic. In this review, molecular and cellular mechanisms of action of clinically useful immunosuppressive drugs are reviewed from the perspective of regulation of the anti-allograft repertory.",
keywords = "immunobiology, immunosuppressive drugs, rejection, tolerance, Transplantation",
author = "Manikkam Suthanthiran and Strom, {Terry B.}",
year = "1995",
month = "7",
day = "1",
doi = "10.1007/BF01541085",
language = "English",
volume = "15",
pages = "161--171",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Immunobiology and immunopharmacology of organ allograft rejection

AU - Suthanthiran, Manikkam

AU - Strom, Terry B.

PY - 1995/7/1

Y1 - 1995/7/1

N2 - Much has been learned regarding immunobiological mechanisms responsible for the rejection of histoincompatible allografts. There has also been considerable progress in our understanding of mechanisms responsible for tolerance. The new knowledge gained regarding graft destructive alloimmunity process and the mechanisms of action of immunosuppressants have resulted in solid organ graft survival rates that are in excess of 80% at one year posttransplantation. The principles of tolerance mechanisms are yet to be successfully applied in the clinic. In this review, molecular and cellular mechanisms of action of clinically useful immunosuppressive drugs are reviewed from the perspective of regulation of the anti-allograft repertory.

AB - Much has been learned regarding immunobiological mechanisms responsible for the rejection of histoincompatible allografts. There has also been considerable progress in our understanding of mechanisms responsible for tolerance. The new knowledge gained regarding graft destructive alloimmunity process and the mechanisms of action of immunosuppressants have resulted in solid organ graft survival rates that are in excess of 80% at one year posttransplantation. The principles of tolerance mechanisms are yet to be successfully applied in the clinic. In this review, molecular and cellular mechanisms of action of clinically useful immunosuppressive drugs are reviewed from the perspective of regulation of the anti-allograft repertory.

KW - immunobiology

KW - immunosuppressive drugs

KW - rejection

KW - tolerance

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0029128133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029128133&partnerID=8YFLogxK

U2 - 10.1007/BF01541085

DO - 10.1007/BF01541085

M3 - Article

C2 - 7593462

AN - SCOPUS:0029128133

VL - 15

SP - 161

EP - 171

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 4

ER -